The protective role of steroids in ischemia-reperfusion injury of the liver

Carlo Pulitanò, Luca Aldrighetti

Research output: Contribution to journalArticle

Abstract

Liver ischemia-reperfusion injury occurs in a number of clinical settings, including liver surgery, transplantation, and circulatory shock, leading to significant morbidity and mortality. There is a substantial evidence that hepatic ischemia-reperfusion injury results from an intense inflammatory response initiated by oxidative stress in the liver parenchyma during reperfusion. The anti-inflammatory effects of glucocorticosteroids (GCs) have been known for decades and have found extensive therapeutic use in a wide range of clinical situations associated with organ ischemia. Based on their biological effects, routine perioperative GCs administration has been advocated to reduce hepatic ischemic injury. However, the use of GCs in hepatic surgery remains controversial and clinical benefits are still uncertain. The aim of review is to present the experimental and clinical evidence about the role of GCs in modulating hepatic ischemia-reperfusion injury.

Original languageEnglish
Pages (from-to)496-503
Number of pages8
JournalCurrent Pharmaceutical Design
Volume14
Issue number5
DOIs
Publication statusPublished - Feb 2008

Fingerprint

Reperfusion Injury
Steroids
Liver
Therapeutic Uses
Liver Transplantation
Reperfusion
Shock
Oxidative Stress
Anti-Inflammatory Agents
Ischemia
Morbidity
Mortality
Wounds and Injuries

Keywords

  • Glucocorticoids
  • Glucocorticosteroids
  • Hepatic ischemia-reperfusion injury
  • Liver surgery
  • Steroids
  • Surgical stress

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

The protective role of steroids in ischemia-reperfusion injury of the liver. / Pulitanò, Carlo; Aldrighetti, Luca.

In: Current Pharmaceutical Design, Vol. 14, No. 5, 02.2008, p. 496-503.

Research output: Contribution to journalArticle

@article{d02e437d4b584368aaa79f8d8141c35f,
title = "The protective role of steroids in ischemia-reperfusion injury of the liver",
abstract = "Liver ischemia-reperfusion injury occurs in a number of clinical settings, including liver surgery, transplantation, and circulatory shock, leading to significant morbidity and mortality. There is a substantial evidence that hepatic ischemia-reperfusion injury results from an intense inflammatory response initiated by oxidative stress in the liver parenchyma during reperfusion. The anti-inflammatory effects of glucocorticosteroids (GCs) have been known for decades and have found extensive therapeutic use in a wide range of clinical situations associated with organ ischemia. Based on their biological effects, routine perioperative GCs administration has been advocated to reduce hepatic ischemic injury. However, the use of GCs in hepatic surgery remains controversial and clinical benefits are still uncertain. The aim of review is to present the experimental and clinical evidence about the role of GCs in modulating hepatic ischemia-reperfusion injury.",
keywords = "Glucocorticoids, Glucocorticosteroids, Hepatic ischemia-reperfusion injury, Liver surgery, Steroids, Surgical stress",
author = "Carlo Pulitan{\`o} and Luca Aldrighetti",
year = "2008",
month = "2",
doi = "10.2174/138161208783597353",
language = "English",
volume = "14",
pages = "496--503",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "5",

}

TY - JOUR

T1 - The protective role of steroids in ischemia-reperfusion injury of the liver

AU - Pulitanò, Carlo

AU - Aldrighetti, Luca

PY - 2008/2

Y1 - 2008/2

N2 - Liver ischemia-reperfusion injury occurs in a number of clinical settings, including liver surgery, transplantation, and circulatory shock, leading to significant morbidity and mortality. There is a substantial evidence that hepatic ischemia-reperfusion injury results from an intense inflammatory response initiated by oxidative stress in the liver parenchyma during reperfusion. The anti-inflammatory effects of glucocorticosteroids (GCs) have been known for decades and have found extensive therapeutic use in a wide range of clinical situations associated with organ ischemia. Based on their biological effects, routine perioperative GCs administration has been advocated to reduce hepatic ischemic injury. However, the use of GCs in hepatic surgery remains controversial and clinical benefits are still uncertain. The aim of review is to present the experimental and clinical evidence about the role of GCs in modulating hepatic ischemia-reperfusion injury.

AB - Liver ischemia-reperfusion injury occurs in a number of clinical settings, including liver surgery, transplantation, and circulatory shock, leading to significant morbidity and mortality. There is a substantial evidence that hepatic ischemia-reperfusion injury results from an intense inflammatory response initiated by oxidative stress in the liver parenchyma during reperfusion. The anti-inflammatory effects of glucocorticosteroids (GCs) have been known for decades and have found extensive therapeutic use in a wide range of clinical situations associated with organ ischemia. Based on their biological effects, routine perioperative GCs administration has been advocated to reduce hepatic ischemic injury. However, the use of GCs in hepatic surgery remains controversial and clinical benefits are still uncertain. The aim of review is to present the experimental and clinical evidence about the role of GCs in modulating hepatic ischemia-reperfusion injury.

KW - Glucocorticoids

KW - Glucocorticosteroids

KW - Hepatic ischemia-reperfusion injury

KW - Liver surgery

KW - Steroids

KW - Surgical stress

UR - http://www.scopus.com/inward/record.url?scp=42049094453&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42049094453&partnerID=8YFLogxK

U2 - 10.2174/138161208783597353

DO - 10.2174/138161208783597353

M3 - Article

C2 - 18289076

AN - SCOPUS:42049094453

VL - 14

SP - 496

EP - 503

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 5

ER -